XML 57 R42.htm IDEA: XBRL DOCUMENT

Segment Reporting (Tables)

12 Months Ended

Jun. 30, 2024

Statement [LineItems]

Disclosure of Operating Segment Information


Operating segment information June 30, 2024		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			—				—				—
Other income
Research material sales			119,089				—				119,089
Grant income			3,722,788				—				3,722,788
Net gain on foreign exchange			—				113,458				113,458
Interest income			—				3,882,757				3,882,757

Total revenue and other income			3,841,877				3,996,215				7,838,092

Result
Segment Result			(46,556,929	)			3,840,304				(42,716,625	)

Profit/(loss) before income tax expense			(46,556,929	)			3,840,304				(42,716,625	)

Income tax expense			—				—				—

Loss after income tax expense											(42,716,625	)
Total segment assets			201,579,281				—				201,579,281
Total segment liabilities			12,057,539				—				12,057,539


Operating segment information June 30, 2023		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			—				—				—
Other income
Research material sales			191,721				—				191,721
Grant income			3,314,001				—				3,314,001
Net gain on fair value movement of warrants			—				131,896				131,896
Net gain on foreign exchange			—				623,511				623,511
Interest income			—				938,999				938,999

Total revenue and other income			3,505,722				1,694,406				5,200,128

Result
Segment Result			(41,431,305	)			1,534,957				(39,896,348	)
Profit/(loss) before income tax expense			(41,431,305	)			1,534,957				(39,896,348	)
Income tax expense			—				—				—
Loss after income tax expense											(39,896,348	)

Total segment assets			147,448,990				—				147,448,990
Total segment liabilities			10,979,601				—				10,979,601


Operating segment information June 30, 2022		Immunotherapy A$				Unallocated A$				Consolidated A$
Revenue
License revenue			170,369				—				170,369
Other income
Research material sales			84,018				—				84,018
Grant income			4,459,974				—				4,459,974
Net gain on fair value movement of warrants			—				591,070				591,070
Net gain on foreign exchange			—				1,228,122				1,228,122
Interest income			—				224,520				224,520

Total revenue and other income			4,714,361				2,043,712				6,758,073

Result
Segment Result			(33,929,768	)			(1,718,976	)			(32,210,792	)

Profit/(loss) before income tax expense			(33,929,768	)			(1,718,976	)			(32,210,792	)
Income tax expense											(34	)

Loss after income tax expense											(32,210,826	)

Total segment assets			102,169,550				—				102,169,550
Total segment liabilities			8,092,184				—				8,092,184